Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
9,885 total articles
Porch Group's Chief Financial Officer, Shawn Tabak, executed a sale of company stock valued at $302,520. This transaction was conducted under a prearranged Rule 10b5-1 trading plan for tax planning purposes. Separately, the company reported mixed results for Q1 2026, posting an EPS beat but significantly missing revenue expectations.
A director at Jack in the Box Inc. recently acquired shares, signaling continued interest despite broader market pressures and mixed operational results reported by the company. The acquisition comes against a backdrop where financial analysts have issued multiple downgrades and reduced price targets due to concerns over sales performance and the b…
The Chairman and CEO of Packaging Corp of America, Mark W. Kowlzan, sold a notable amount of company stock in late May 2026. This transaction occurred while the stock was trading at elevated levels and following several positive developments for PKG, including dividend increases and upgrades from major financial institutions. Sector news also highl…
Thomas Rutledge, Director Emeritus at Charter Communications (NASDAQ:CHTR), executed multiple stock sales totaling approximately $12.73 million in late May 2026. The transactions involved his personal holdings and shares held in trusts for his adult children. This activity occurs as the company's stock price trades near $147, contrasting with a 64%…
Margaret E. Haas, a significant shareholder and ten percent owner of Levi Strauss & Co (NASDAQ:LEVI), reported the disposition of Class A Common Stock on May 27, 2026. These transactions were conducted through established trading plans and benefit charitable entities. Despite the sale, recent corporate performance metrics and subsequent analyst act…
Judy Bruner, a director at Applied Materials Inc., recently sold shares valued at $507,600. This transaction occurred while the company's stock was trading near its 52-week high and amidst significant positive analyst coverage related to AI compute demand and advanced chip packaging solutions for the semiconductor sector.
David Mark O’Hara, a director at CADIZ INC (CDZI), recently purchased shares of the company's common stock. This insider transaction occurs against a backdrop of positive corporate development, notably Cadiz Inc.'s funding agreement with the U.S. Bureau of Reclamation to support technical and regulatory reviews for the Mojave Groundwater Bank proje…
The Peter E. Haas Jr. Family Fund, a significant stakeholder in Levi Strauss & Co., reported selling shares on May 27, 2026. This transaction was executed through a pre-arranged Rule 10b5-1 plan. The sale took place when the stock was near its recent 52-week high. Despite the insider selling, the company has also received positive analyst reactions…
Director Bernardo Hees made multiple transactions acquiring Krispy Kreme stock between May 26 and May 28, 2026. These purchases occurred while the company's shares trade significantly above their 52-week low, although valuation analysis suggests potential overvaluation relative to fair value. The insider buying activity follows a first-quarter repo…
Chief Commercial Officer (CCO) Earl Thomas sold $12.4 million worth of Venture Global's Class A Common Stock on May 27, 2026, following the exercise of stock options. This sale occurred against a backdrop of mixed financial signals for the company: while recent revenue growth was substantial, the firm reported Q1 2026 earnings per share (EPS) signi…
A recent SEC filing revealed that Jack in the Box director Guillermo Diaz Jr. acquired a significant block of company stock. This insider activity takes place against a backdrop of mixed analyst reactions, including downgrades and lowered price targets, despite better-than-expected EBITDA results for the second quarter. The company is managing near…
Musser Fory, Senior VP of Development at Venture Global, Inc. (NASDAQ:VG), recently conducted two significant sales totaling over $6.4 million worth of Class A Common Stock on May 26 and May 27, 2026. These transactions occurred while the stock was trading below InvestingPro’s calculated Fair Value. The activity is viewed against a backdrop of rece…
SEC filings confirm that Kristine Kay Malkoski, President of Learning & Development at Newell Brands Inc., recently sold common stock. This transaction occurred against a backdrop of positive corporate developments for the company, including stronger-than-expected first quarter 2026 financials and upward revisions to full-year sales and earnings ou…
The analysis covers mixed activity surrounding FTAI Infrastructure Inc. (FIP), noting that the Chief Financial Officer recently purchased common stock despite the company facing a significant earnings per share shortfall in Q1 2026. This backdrop is tempered by an upgrade from Moody's Ratings to FTAI Aviation Ltd., which cites strong performance an…
Chief Executive Officer Cheryl Beranek sold $125,000 worth of Clearfield, Inc. (NASDAQ:CLFD) common stock on May 27, 2026. This transaction occurred despite the stock having recently surged significantly. The company also reported fiscal second-quarter 2026 earnings that missed analyst forecasts for both EPS and revenues.
Ronda E. Stryker, a director at medical technology firm Stryker Corp (NASDAQ:SYK), recently sold shares valued at approximately $96.8 million. This transaction occurred against a backdrop of mixed company performance, including significant revenue and EPS shortfalls reported in Q1 2026 due to a cyber incident. Despite the operational setbacks, Stry…
Director Brian S. Posner of Dyne Therapeutics, Inc. (NASDAQ:DYN) recently increased his personal investment in the company's common stock through a direct acquisition. This insider activity occurs against a backdrop of significant clinical and regulatory developments concerning the company's approach to Duchenne muscular dystrophy (DMD). The purcha…
Fulgent Genetics' COO, Jian Xie, sold a block of common shares to cover tax withholding related to vested restricted units. While the company recently reported first-quarter financial results that fell short of analyst expectations, management continues to detail several key initiatives, including a new pharmacogenetic testing service with Foundati…
Chief People Officer Melissa Luff Loizides recently sold shares of Zebra Technologies Corp. (NASDAQ:ZBRA). This transaction occurred against a backdrop of highly positive corporate news, including robust first-quarter 2026 earnings and subsequent guidance increases, which have prompted several major financial institutions to raise price targets and…
Datadog Chief Executive Officer Olivier Pomel sold a substantial amount of company stock totaling approximately $18.9 million on May 26, 2026. This transaction occurs while the stock trades near its yearly high, following strong first-quarter earnings reports and receiving significant government certifications.
Senior Vice President Lance Soliday sold a portion of his common stock in Expedia Group, Inc. This transaction occurs against a backdrop of significant corporate developments, including the planned acquisition of CarTrawler and the introduction of new AI-powered business tools. While analysts have issued differing price target adjustments following…
Black Stone Minerals, L.P. (NASDAQ:BSM) director D. Mark DeWalch recently purchased a substantial number of company common units. This transaction, totaling approximately $497,341, signals significant insider buying activity. Furthermore, recent financial reports for the first quarter of 2026 showed mixed results, with strong revenue performance bu…
Chief Global Commercialization Officer Anthony Mancini recently executed transactions involving Revolution Medicines, Inc. (NASDAQ:RVMD) common stock, selling shares under an established 10b5-1 trading plan. These sales occurred as the company's stock trades near its 52-week high. Beyond the insider activity, recent corporate developments include t…
Paul Schimmel, a director at aTYR Pharma Inc., recently purchased $49,630 worth of common stock. This activity occurs while the company progresses with drug development, including plans for a new Phase 3 study of efzofitimod. Furthermore, Jefferies maintained a Buy rating on the stock, citing potential shifts in medical practice.
Target executive Brian C. Cornell sold approximately $6.49 million worth of the company's common stock in transactions completed on May 27, 2026. This activity occurred as Target shares trade near $128.65, despite showing a 44% increase over the past six months. The report also details recent positive operational news for Target, including strong f…
